Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jun;30(3):245-51.
doi: 10.1097/JCP.0b013e3181da5406.

Effects of cholinesterase inhibitors on visual attention in drivers with Alzheimer disease

Lori A Daiello  1 , Brian R Ott, Elena K Festa, Michael Friedman, Lindsay A Miller, William C Heindel
Affiliations
Comparative Study

Effects of cholinesterase inhibitors on visual attention in drivers with Alzheimer disease

Lori A Daiello et al. J Clin Psychopharmacol. 2010 Jun.

Abstract

Objective: We conducted a combined observational cohort and case-control study in patients with Alzheimer disease (AD) to assess the effects of acetylcholinesterase inhibitor (ChEI) treatment on cognitive functions important for driving.

Methods: Performance of 24 outpatients with newly diagnosed (untreated) early-stage AD was compared before beginning ChEI (pre-ChEI) and after 3 months of therapy (post-ChEI) on a set of computerized tests of visual attention and executive function administered under both single-task and dual-task conditions. To address the limitation of a lack of an untreated control group in this observational cohort study, performance of 35 outpatients with newly diagnosed (untreated) early-stage AD (ChEI nonusers) were also compared with a demographically matched group of AD patients treated with stable doses of a ChEI (ChEI users) on these tasks.

Results: Performance was consistently worse under dual-task than single-task conditions regardless of ChEI treatment status. However, ChEI treatment consistently affected specific components of attention within each test across both sets of comparisons: ChEI treatment enhanced simulated driving accuracy and was associated with significantly better visual search target detection accuracy and response time in both pre-ChEI-post-ChEI and users-nonusers treatment comparisons. Cholinesterase inhibitor treatment also improved overall time to complete a set of mazes while not affecting accuracy of completion.

Conclusions: Cholinesterase inhibitor treatment was associated with improvements in tests of executive function and visual attention. These findings could have important implications for patients who continue to drive in the early stages of AD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustrations of the displays for (A) the simulated driving with visual search task and (B) the maze navigation task.
See this image and copyright information in PMC

References

    1. Dubinsky RM, Stein AC, Lyons K. Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;54:2205–2211. - PubMed
    1. Hoffman L, McDowd JM, Atchley P, et al. The role of visual attention in predicting driving impairment in older adults. Psychol Aging. 2005;20:610–622. - PubMed
    1. Wezenberg E, Verkes RJ, Sabbe BG, et al. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology (Berl) 2005;181:582–594. - PubMed
    1. Yesavage JA, Mumenthaler MS, Taylor JL, et al. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology. 2002;59:123–125. - PubMed
    1. Mumenthaler MS, Yesavage JA, Taylor JL, et al. Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacology. 2003;28:1366–1373. - PubMed

Publication types

MeSH terms

Substances